MPR - Medical Professionals Reference

01/10/2025

Oral option approved to treat chronic spontaneous urticaria.

Rhapsido is supplied as a 25mg tablet.

30/09/2025

Recently approved eye drop to treat presbyopia now available.

Vizz eye drops contain a cholinergic muscarinic agonist that causes contraction of the iris sphincter muscle, resulting in a pinhole effect that extends focus depth to improve vision in presbyopia.

29/09/2025

Tremfya gets OK'd for patients 6 years and older. https://www.empr.com/news/tremfya-approved-for-children-with-plaque-psoriasis-psoriatic-arthritis/

29/09/2025

Sign up today for our bi-weekly email covering emerging research, conference news, and guideline updates on neurocognitive disorders, headache and pain syndromes, and cerebrovascular diseases: https://bit.ly/4khdEep

29/09/2025

Qivigy supplies a broad spectrum of opsonizing and neutralizing IgG antibodies against bacterial and viral agents. https://www.empr.com/news/qivigy-approved-for-primary-humoral-immunodeficiency-in-adults/

26/09/2025

🎧 Latest MPR Pod out now and its been a week!
🔹 CDC recs changes to MMRV vax;
🔸 Trump admin make acetaminophen-autism claim;
🔹 Barth syndrome Tx gets green light;
🔸 Breakthrough in Huntington disease; and
🔹 SC formulation of Keytruda.
https://www.empr.com/news/mpr-weekly-dose-podcast-250/

25/09/2025

Trial demonstrates big breakthrough in Huntington disease. https://www.empr.com/news/gene-therapy-slows-huntington-disease-progression-in-pivotal-trial/

24/09/2025

Trial demonstrates success in Huntington disease, slowing disease progression by 75%.

After 36 months, patients treated with high dose AMT-130 saw a 75% slowing of disease progression vs the external control.

24/09/2025

Intranasal carbetocin misses in Prader-Willi syndrome trial.

The COMPASS PWS trial was a 12-week, randomized, double-blind, placebo-controlled, parallel-group study that included 175 patients aged 5 to 30 years with PWS.

22/09/2025

FDA Commissioner Marty Makary said the FDA will begin the process of updating the labels for acetaminophen products to include new safety information regarding this risk.

The announcement comes after a recently published review showed an association between prenatal acetaminophen exposure and an increased risk of autism.

22/09/2025

Sign up today for our bi-weekly email covering emerging research, conference news, and guideline updates on general oncology, breast cancer and lung cancer: https://bit.ly/44KazPe

22/09/2025

California, Hawaii, Oregon and Washington recommend COVID-19 shots for young children, older adults and pregnant women. https://www.empr.com/news/west-coast-states-issue-their-own-covid-flu-rsv-vaccine-rules/